| Y/e 31 Mar( In .Cr) | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 |
|---|---|---|---|---|
Equity Capital | 28.22 | 28.22 | 28.22 | 28.22 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 24,122.1 | 24,475.74 | 22,942.4 | 17,849.25 |
Net Worth | 24,150.32 | 24,503.96 | 22,970.62 | 17,877.47 |
Minority Interest | ||||
Debt | 107.01 | 829.79 | 707.29 | 3,221.22 |
Deferred Tax Liability Net | 962.57 | 224.85 | 309.77 | 213.5 |
Total Liabilities | 25,219.9 | 25,558.6 | 23,987.68 | 21,312.19 |
Fixed Assets | 2,187.22 | 2,133.74 | 1,953.91 | 1,918.28 |
Intangible Assets | ||||
Investments | 15,202.21 | 15,194.91 | 12,964.79 | 10,334.01 |
Deferred Tax Asset Net | 968.61 | 166.59 | 475.61 | 1,160.25 |
Networking Capital | 6,568.67 | 7,930.63 | 8,464.23 | 7,805.84 |
Inventories | 1,288.06 | 1,369.31 | 1,142.69 | 1,090.21 |
Inventory Days | ||||
Sundry Debtors | 3,305.59 | 2,550.16 | 2,484.47 | 2,505.66 |
Debtor Days | ||||
Other Current Assets | 7,202.87 | 6,652.44 | 8,573.54 | 7,697.21 |
Sundry Creditors | -2,764.93 | -2,197.2 | -2,767.93 | -2,134.85 |
Creditor Days | ||||
Other Current Liabilities | -2,462.92 | -444.08 | -968.54 | -1,352.39 |
Cash | 293.19 | 132.74 | 129.15 | 93.79 |
Total Assets | 25,219.9 | 25,558.61 | 23,987.69 | 21,312.17 |
Revenue from North America increased 24% year on year to ₹970.6 crore, including income from the out licensing of ISB 2001.
Here are some of the stocks that may see significant price movement today: Polycab India, Tata Steel, Dalmia Bharat, etc.
Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Rail Vikas Nigam, Birla Corp, etc.
At around 2.19 PM, Glenmark Pharma was trading 2.97% higher at ₹2,112.90 per piece, against the previous close of ₹2,051.90 on NSE.
Operating performance was slightly weaker, with EBITDA dipping 1.4% to ₹580 crore from ₹588.2 crore.
Here are some of the stocks that may see significant price movement today: Glenmark Pharmaceuticals, Vedanta, Inox Wind, etc.
The compound is currently in Phase 1B clinical trials, being studied for multiple myeloma, a tough-to-treat form of blood cancer.
Here are some of the stocks that may see significant price movement today: Tata Consultancy Services, IREDA, Glenmark Pharma, etc.
Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Ashok Leyland, NTPC, etc.
ISB 2001 is a tri-specific antibody therapeutic for targeting BCMA and CD38 on myeloma cells, as well as CD3 on T cells.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
